Garcia, Joe G. N.
- University of Florida · Internal Medicine (NIH department code)
- Aqualung Therapeutics Corp. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #624
- Rising Star
- Sustained Excellence
- Program Leader
- Top 5% Funded
- Long-Funded
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$5.5M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#624
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Garcia, Joe G. N. as a PI. Multi-PI records show the full award amount for context.
- 7P01HL126609-07P01Contact PICytoskeletal Regulation of Lung Endothelial Pathobiology in ARDSUniversity of Florida · Internal Medicine (NIH department code)$2.2Maward amount
- 2R44HL145930-04R44Contact PIA Randomized Phase 2A Clinical Trial Pioneering the Utility of an eNAMPT-Reducing Therapy in ARDS/VILI: the PUERTA Trial$1.5Maward amount
- 4R42DK135208-02R42Contact PITargeting the eNAMPT/TLR4 pathway to reduce Inflammatory Bowel Disease severity$975.2Kaward amount
- 4R42HL164300-02R42Contact PIPreclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension$809Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Garcia, Joe G. N. as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardAqualung Therapeutics Corp.
- 2006$500K Cumulative Funding
- 2006$1M Cumulative Funding
- 2006$2M Cumulative Funding
- 2006Entered Top 50% NationallyRanked #1619
- 2006Entered Top 25% NationallyRanked #1619
- 2006Entered Top 10% NationallyRanked #1619
- 2007Multi-Institutional ResearchAwards at 2 institutions
- 2008$5M Cumulative Funding
- 2009$10M Cumulative Funding
- 2015Program/Center Grant Leader
- 2017$25M Cumulative Funding
- 2020Entered Top 5% NationallyRanked #375
- 2023$50M Cumulative Funding